Ausupreme International Holdings (HKSE:02031) Research & Development: HK$0.0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02031 Ausupreme International Holdings Ltd HKSE:02031
58 GF Score
Price HK$0.49
GF Value HK$0.36
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Ausupreme International Holdings Research & Development?

Ausupreme International Holdings HKSE:02031 58 Research & Development is HK$0.0 Mil as of Mar. 2026. GuruFocus rates HKSE:02031 with a GF Score™ of 58/100 and a GF Value™ of HK$0.36 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Ausupreme International Holdings's Research & Development for the six months ended in Mar. 2026 was HK$0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was HK$0.0 Mil.

Ausupreme International Holdings  (HKSE:02031) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Ausupreme International Holdings Research & Development Related Terms

Ausupreme International Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for Ausupreme International Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ausupreme International Holdings Research & Development Chart

Ausupreme International Holdings Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Ausupreme International Holdings Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
HKSE:02031
58GF Score
Ausupreme International Holdings Ltd HKSE:02031
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ausupreme International Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of HK$0.0 Mil mean?
Ausupreme International Holdings (HKSE:02031) has a Research & Development of HK$0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Ausupreme International Holdings and its competitors.
Is Ausupreme International Holdings' Research & Development too high?
Ausupreme International Holdings' current Research & Development is HK$0.0 Mil. Overall, Ausupreme International Holdings has a GF Score™ of 58/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ausupreme International Holdings' Research & Development compare to PG and CL?
Ausupreme International Holdings' Research & Development of HK$0.0 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Consumer Packaged Goods company?
A good Research & Development depends on the Consumer Packaged Goods industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Ausupreme International Holdings and its competitors. Ausupreme International Holdings's current Research & Development is HK$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ausupreme International Holdings stock overvalued right now?
Based on GuruFocus' analysis, Ausupreme International Holdings (HKSE:02031) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.36, compared to a current price of HK$0.49 — trading 36.1% above its estimated fair value. The current Research & Development is HK$0.0 Mil. Ausupreme International Holdings' overall GF Score™ is 58/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Ausupreme International Holdings (HKSE:02031), the current Research & Development is HK$0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ausupreme International Holdings (HKSE:02031) Overvalued in 2026?

Based on GuruFocus' analysis, Ausupreme International Holdings stock appears to be overvalued. The current stock price of HK$0.49 is trading 36.1% above its estimated GF Value™ of HK$0.36. GuruFocus considers Ausupreme International Holdings to be Significantly Overvalued.

Key valuation signals for HKSE:02031:

  • Research & Development: HK$0.0 Mil
  • GF Value™: HK$0.36 vs. price of HK$0.49 (36.1% above fair value)
  • GF Score™: 58/100 with 6 warning signs

No single metric tells the full story. See the HKSE:02031 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ausupreme International Holdings Business Description

Address 83 Hung To Road, Office E, 30th Floor, EGL Tower, Kwun Tong, Kowloon, Hong Kong, HKG
Ausupreme International Holdings Ltd is principally a Hong Kong-based brand builder, retailer, and wholesaler of health and personal care products focusing on the development, marketing, sales, and distribution of branded products. The revenue is recognized from the sale of health supplement products, honey and pollen products, and personal care products. The vast majority is earned from the sale of health supplement products. Geographically, the group derives maximum revenue from Hong Kong, followed by Mainland China, Macau, and Singapore.
58GF Score

Get the complete analysis for HKSE:02031

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.49
Price
HK$0.36
GF Value